PubMed:24224997 / 3012-3247
Annnotations
PubMed_Structured_Abstracts
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 0-235 | CONCLUSIONS | denotes | TARGIT concurrent with lumpectomy within a risk-adapted approach should be considered as an option for eligible patients with breast cancer carefully selected as per the TARGIT-A trial protocol, as an alternative to postoperative EBRT. |
luoyt2021_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 126-139 | DP | denotes | breast cancer |
Linmchun_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T4 | 126-139 | DP | denotes | breast cancer |